Gillian Moore

FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer

Stephanie Annett, Gillian Moore, Amy Short et al. · British Journal of Cancer · 2019 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17

Parallel Profiles of Inflammatory and Effector Memory T Cells in Visceral Fat and Liver of Obesity-Associated Cancer Patients

Melissa J. Conroy, Karen Galvin, Suzanne L. Doyle et al. · Inflammation · 2016 · 19 citations · Full text

Life Sciences, Immunology, Oncology +17

The immunophilin protein FKBPL and its peptide derivatives are novel regulators of vascular integrity and inflammation via NF-κB signaling

Stephanie Annett, Shaun Spence, Carolina D. Garciarena et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 14 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC

Gillian Moore, Clara Lightner, Samira Elbai et al. · Cancers · 2021 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

Development and characterisation of a panel of phosphatidylinositide 3-kinase – mammalian target of rapamycin inhibitor resistant lung cancer cell lines

Susan Heavey, Paul Dowling, Gillian Moore et al. · Scientific Reports · 2018 · 13 citations · Full text

Medicine, Oncology, Pharmacology +16